Analgesic Services Inc. Competitors

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 825* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,400 employees worldwide. *As of March 2026 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at PV@hikma.com

Guided by our belief that better is possible, we innovate and deliver therapies that reimagine life beyond pain, empowering patients and clinicians with advanced options that challenge the status quo of care. Pacira BioSciences, Inc. is a pioneer in non-opioid pain management and is steadfast in its commitment to transforming how pain is treated and experienced. Since our inception in 2006, Pacira has been at the forefront of addressing unmet needs in pain management. From pioneering targeted, long-acting non-opioid therapies to advancing treatments that set new standards in patient care, we are redefining what’s possible for patients. Headquartered in Brisbane, CA with additional offices in San Diego, CA, Parsippany, NJ, Tampa, FL, and Swindon, UK, our team of over 800 dedicated employees is focused on establishing new benchmarks in pain management. Integrity, collaboration, and an unwavering commitment to excellence guide everything we do. As we expand our portfolio and explore cutting-edge innovations such as gene therapy, we remain focused on improving patient outcomes and enhancing lives. Intended for US audiences. Discover how we’re transforming pain management at pacira.com/company/impact/

Purdueand its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers. Purdue and its subsidiaries focus on balancing innovative science with clinically effective, compassionate care. The Company’s goals are to serve patients who rely on its medicines, pursue public health initiatives intended to help abate the opioid crisis, advance its pipeline of branded and generic medications, and introduce medicines that will help save and improve lives.